Allergy Diagnostics Market Worth $9.8 billion | MarketsandMarkets - Seite 3

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

Allergy Diagnostics Market Dynamics:

Drivers:

1.  High incidence and heavy economic burden of allergic diseases

Restraints:

1.  High pricing of allergy diagnostic instruments

Opportunities:

1.  Integration of AI in allergy diagnosis

Challenge:

1.  Shortage of allergists

Key Market Players of Allergy Diagnostics Industry:

Major players in Allergy Diagnostics market include Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan), Minaris Medical America, Inc. (US).

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (36%), Asia- Pacific (27%), Europe (25%), and Latin America- (7%) and MEA-(5%)

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=232871701

Recent Developments of Allergy Diagnostics Industry:

• In 2023, Canon has completed share transfer procedures with Resonac Corporation. This share transfer is intended to be used to purchase the Resonac subsidiaries Minaris Medical Co., Ltd. and Minaris Medical America, Inc. (collectively, "Minaris Medical"). After this share acquisition is finished, Minaris Medical—which runs companies that deal with automated analytical tools and in vitro diagnostic reagents—will be consolidated under Canon Medical.
• In 2023, Romer Labs Division Holding GmbH (Austria) acquired CPAK INTER Co., Ltd. (Thailand), a long-time distributor of Romer Labs solutions based in Bangkok. With the acquisition, Romer Labs has achieved yet another significant milestone in the quickly expanding Asian food safety industry.
• In 2022, The US Food & Drug Administration (FDA) has cleared ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies, according to a statement from Thermo Fisher Scientific, Inc. (US).

Allergy Diagnostics Market - Key Benefits of Buying the Report: